You just read:

Innovent Biologics and MD Anderson Announce a Strategic Collaboration to Develop anti-PD-1 Therapy TYVYT® (Sintilimab Injection) in Rare Cancers

News provided by

Innovent Biologics, Inc.

May 18, 2020, 19:30 ET